GlycArt Biotechnology's Acquisition

GlycArt Biotechnology was acquired by Roche Holding on July 19, 2005.

GlycArt is a Swiss biotechnology company focused on the development and commercialization of a new generation of antibody products based on its proprietary GlycoMAb technology. GlycoMAb has the potent…

Articles about GlycArt Biotechnology's Acquisition: